What is the equity of Antisense Therapeutics this year?
Antisense Therapeutics has equity of 9.98 M AUD this year.
Antisense Therapeutics Equity 2024
Antisense Therapeutics Equity
9.98 M AUD
Ticker
ANP.AX
ISIN
AU000000ANP4
WKN
982306
In 2024, Antisense Therapeutics's equity was 9.98 M AUD, a -52.81% increase from the 21.14 M AUD equity in the previous year.
Antisense Therapeutics Aktienanalyse
What does Antisense Therapeutics do?
Antisense Therapeutics Ltd is an Australian biopharmaceutical company that focuses on developing novel therapies for rare and severe diseases. The company was founded in 1987 and is headquartered in Melbourne. Antisense Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Antisense Therapeutics's Equity
Antisense Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Antisense Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Antisense Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Antisense Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Antisense Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Antisense Therapeutics stock
What was the equity of Antisense Therapeutics compared to the previous year?
The equity of Antisense Therapeutics has increased/decreased by -52.81% decreased compared to the previous year.
What impact does a high equity have on investors of Antisense Therapeutics?
A high equity is advantageous for investors of Antisense Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Antisense Therapeutics?
A low equity can be a risk for investors of Antisense Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Antisense Therapeutics affect the company?
An increase in equity of Antisense Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Antisense Therapeutics affect the company?
A reduction in equity of Antisense Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Antisense Therapeutics?
Some factors that can affect the equity of Antisense Therapeutics include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Antisense Therapeutics so important for investors?
The equity of Antisense Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Antisense Therapeutics take to change the equity?
To change equity, Antisense Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Antisense Therapeutics pay?
Over the past 12 months, Antisense Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Antisense Therapeutics is expected to pay a dividend of 0 AUD.
What is the dividend yield of Antisense Therapeutics?
The current dividend yield of Antisense Therapeutics is .
When does Antisense Therapeutics pay dividends?
Antisense Therapeutics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Antisense Therapeutics?
Antisense Therapeutics paid dividends every year for the past 0 years.
What is the dividend of Antisense Therapeutics?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Antisense Therapeutics located?
Antisense Therapeutics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Antisense Therapeutics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Antisense Therapeutics from 9/26/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.
When did Antisense Therapeutics pay the last dividend?
The last dividend was paid out on 9/26/2024.
What was the dividend of Antisense Therapeutics in the year 2023?
In the year 2023, Antisense Therapeutics distributed 0 AUD as dividends.
In which currency does Antisense Therapeutics pay out the dividend?
The dividends of Antisense Therapeutics are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Antisense Therapeutics
Our stock analysis for Antisense Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Antisense Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Antisense Therapeutics Revenue
- Antisense Therapeutics Net Income
- Antisense Therapeutics P/E
- Antisense Therapeutics P/S
- Antisense Therapeutics EBIT
- Antisense Therapeutics Dividend
- Antisense Therapeutics Stocks
- Antisense Therapeutics Market capitalization
- Antisense Therapeutics Debt
- Antisense Therapeutics Liabilities
- Antisense Therapeutics Equity
- Antisense Therapeutics AAQS
- Antisense Therapeutics Employees
- Antisense Therapeutics ROE
- Antisense Therapeutics ROA
- Antisense Therapeutics ROCE
